TRPC6 and polyarteritis nodosa: In contrast, treatments with MP, RTX, and combined RTX and MP for similar time frames resulted in markedly greater reductions of 10%–60% in TRPC6 mRNA levels compared to those observed in the PAN-treated cohort (p < 0.05).